Potential for prevention: a cohort study of colonoscopies and removal of adenomas in a FIT-based colorectal cancer screening programme

被引:7
作者
Larsen, Mette Bach [1 ]
Njor, Sisse Helle [1 ]
Jensen, Thomas Moller [2 ]
Ingeholm, Peter [3 ]
Andersen, Berit [1 ]
机构
[1] Randers Reg Hosp, Dept Publ Hlth Programmes, Skovlyvej 15, DK-8930 Randers NO, Denmark
[2] Horsens Reg Hosp, Dept Internal Med, Horsens, Denmark
[3] Herlev Hosp, Dept Pathol, Herlev, Denmark
关键词
Primary prevention; colorectal neoplasms; mass screening; faeces; adenoma; FECAL IMMUNOCHEMICAL TESTS; OCCULT BLOOD-TESTS; DIAGNOSTIC COLONOSCOPY; ETHICAL-ISSUES; COMPLICATIONS; PARTICIPANTS; PERFORMANCE; HEMOGLOBIN; TRENDS; RISK;
D O I
10.1080/00365521.2019.1647282
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: Evidence suggests that colorectal cancer (CRC) screening using guaiac faecal occult blood tests (gFOBT) reduces the CRC burden by facilitating timely removal of adenomas. Yet, the faecal immunochemical test (FIT) is being implemented in many countries. The aim of this study was to analyse the risk of having adenomas detected when invited for FIT-based screening as compared to those not yet invited. Material and Methods: The study was designed as a register-based retrospective cohort study. The potential for prevention was estimated as number of individuals who had no adenomas, non-advanced adenomas, and advanced adenomas detected per 1000 invited/not yet invited individuals and the relative risk (RR) of each of the three outcomes. Results: A total of 1,359,340 individuals were included, 29.6% of whom had been invited and 70.4% had not yet been invited to participate in CRC screening. Compared with the not yet invited population, the invited group had a RR of no adenomas of 2.28 (2.22-2.34) and a RR of advanced adenomas of 7.41 (6.93-7.91). The RR of colonoscopy was 2.93 (2.87-2.99) for the invited population compared with the not yet invited population. Conclusion: The RR of having a colonoscopy was three times higher among those invited compared to those not yet invited for CRC screening and twice as often those who had been invited compared to those not yet invited had no adenomas detected. Still, the risk of advanced adenomas was more than seven times higher among the invited population, indicating that the screening programme holds great potential for reducing the CRC burden.
引用
收藏
页码:1008 / 1014
页数:7
相关论文
共 36 条
[1]  
[Anonymous], ANB VEDR SCREEN TYK
[2]   Diagnostic value of symptoms for colorectal cancer in primary care: a systematic review [J].
Hamilton, William ;
Astin, Margaret ;
Griffin, Tom ;
Neal, Richard D. ;
Rose, Peter .
BRITISH JOURNAL OF GENERAL PRACTICE, 2011, 61 (586) :e231-e243
[3]   The Danish Pathology Register [J].
Bjerregaard, Beth ;
Larsen, Ole B. .
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2011, 39 :72-74
[4]   Colorectal cancer [J].
Brenner, Hermann ;
Kloor, Matthias ;
Pox, Christian Peter .
LANCET, 2014, 383 (9927) :1490-1502
[5]   Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy [J].
Brenner, Hermann ;
Tao, Sha .
EUROPEAN JOURNAL OF CANCER, 2013, 49 (14) :3049-3054
[6]   Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review [J].
Burch, J. A. ;
Soares-Weiser, K. ;
St John, D. J. B. ;
Duffy, S. ;
Smith, S. ;
Kleijnen, J. ;
Westwood, M. .
JOURNAL OF MEDICAL SCREENING, 2007, 14 (03) :132-137
[7]   Difference in Performance of Fecal Immunochemical Tests With the Same Hemoglobin Cutoff Concentration in a Nationwide Colorectal Cancer Screening Program [J].
Chiang, Tsung-Hsien ;
Chuang, Shu-Lin ;
Chen, Sam Li-Sheng ;
Chiu, Han-Mo ;
Yen, Amy Ming-Fang ;
Chiu, Sherry Yueh-Hsia ;
Fann, Jean Ching-Yuan ;
Chou, Chu-Kuang ;
Lee, Yi-Chia ;
Wu, Ming-Shiang ;
Chen, Hsiu-Hsi .
GASTROENTEROLOGY, 2014, 147 (06) :1317-1326
[8]  
Danish Colorectal Cancer Screening Database, 2014, DANISH COLORECTAL CA
[9]  
Dawwas MF, 2014, NEW ENGL J MED, V370, P2539, DOI [10.1056/NEJMc1405329, 10.1056/NEJMoa1309086]
[10]   Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018 [J].
Ferlay, J. ;
Colombet, M. ;
Soerjomataram, I. ;
Dyba, T. ;
Randi, G. ;
Bettio, M. ;
Gavin, A. ;
Visser, O. ;
Bray, F. .
EUROPEAN JOURNAL OF CANCER, 2018, 103 :356-387